CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults [Phase 3]
Summary
Phase 3 lot-to-lot consistency study of PXVX0200 live oral cholera vaccine completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bavarian Nordic | Conditions: Cholera | Phase 3 | Status: COMPLETED | Results posted: 2021-07-15